EXPEDITION THERAPEUTICS ANNOUNCES OVERSUBSCRIBED $115 MILLION SERIES B FINANCING TO ADVANCE NEXT-GENERATION DPP1 INHIBITOR FOR COPD

Reuters · 3d ago

Please log in to view news